KELLY JUSTYNA 4
4 · POINT Biopharma Global Inc. · Filed Dec 10, 2021
Insider Transaction Report
Form 4
KELLY JUSTYNA
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-09+70,000→ 70,000 totalExercise: $6.40Exp: 2027-12-09→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The option vests 25% on December 9, 2022 with the remaining 75% vesting in three equal annual installments thereafter. Notwithstanding the foregoing, upon any Sale Event (as defined in the Issuer's 2021 Plan), any outstanding stock options shall automatically become fully vested and exercisable as of the effective time of the Sale Event.